TY - JOUR
T1 - Structure-activity relationships of 2′-fluoro-2′,3′-unsaturated d-nucleosides as anti-hiv-1 agents
AU - Lee, Kyeong
AU - Choi, Yongseok
AU - Gumina, Giuseppe
AU - Zhou, Wen
AU - Schinazi, Raymond F.
AU - Chu, Chung K.
PY - 2002/3/14
Y1 - 2002/3/14
N2 - We studied the structure-activity relationships of a series of 2′-fluoro-2′,3′-unsaturated D-nucleosides against HIV-1 in human peripheral blood mononuclear (PBM) cells. The target compounds 10-21 and 28-33 were prepared by N-glycosylation of the acetate 4, which was readily prepared from 2,3-O-isopropylidene-D-glyceraldehyde in five steps. Among the newly synthesized nucleosides, 2-amino-6-chloropurine (11), adenine (14), inosine (16), guanine (18), 2,6-diaminopurine (20), and 5-fluorocytosine (30) derivatives were found to exhibit interesting anti-HIV activities with EC50 values of 4.3, 0.44, 1.0, 2.6, 3.0, and 0.82 μM, respectively. The implications for drug resistance of the titled nucleosides with respect to lamivudine-resistant variants (M184V) were also examined, and no significant cross-resistance with the variants was observed with the D-series.
AB - We studied the structure-activity relationships of a series of 2′-fluoro-2′,3′-unsaturated D-nucleosides against HIV-1 in human peripheral blood mononuclear (PBM) cells. The target compounds 10-21 and 28-33 were prepared by N-glycosylation of the acetate 4, which was readily prepared from 2,3-O-isopropylidene-D-glyceraldehyde in five steps. Among the newly synthesized nucleosides, 2-amino-6-chloropurine (11), adenine (14), inosine (16), guanine (18), 2,6-diaminopurine (20), and 5-fluorocytosine (30) derivatives were found to exhibit interesting anti-HIV activities with EC50 values of 4.3, 0.44, 1.0, 2.6, 3.0, and 0.82 μM, respectively. The implications for drug resistance of the titled nucleosides with respect to lamivudine-resistant variants (M184V) were also examined, and no significant cross-resistance with the variants was observed with the D-series.
UR - http://www.scopus.com/inward/record.url?scp=0037075785&partnerID=8YFLogxK
U2 - 10.1021/jm010418n
DO - 10.1021/jm010418n
M3 - Article
C2 - 11882000
AN - SCOPUS:0037075785
SN - 0022-2623
VL - 45
SP - 1313
EP - 1320
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 6
ER -